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Compliance is a major obstacle to achieving phosphorus control in the majority of patients with end-stage renal disease. 
We investigated self-reported medication adherence and its correlation with serum phosphate levels and nutritional status 
in hemodialysis patients. A total of 417 patients from Croatia, Montenegro and Bosnia and Herzegovina, mean age 63.82 
(range, 21-92) years, were included in the study. There were 55.1% of male patients with the mean dialysis vintage of 
68.67 (range, 3-456) months. A signifi cant positive correlation was found between self-reported adherence and serum 
phosphorus (0.192), and negative correlation with hemoglobin, prealbumin, albumin, Kt/V and residual diuresis (-0.187, 
-0.227, -0.100, 0.192, and -0.106, respectively). On the other hand, the number of pills taken daily correlated signifi cantly 
with residual diuresis, serum prealbumin, serum glucose, triglycerides, ferritin and ultrafi ltration volume (0.241, 0.154, 0.158, 
0.112, 0.201 and 0.125, respectively). In conclusion, self-reported medication adherence correlates with serum phosphate 
levels, residual diuresis and nutritional status in hemodialysis patients.
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INTRODUCTION
Hemodialysis patients have numerous limitations and 
require multiple drugs to correct abnormalities asso-
ciated with chronic kidney disease (CKD). Accumu-
lation of phosphorus is an important problem in this 
population, which af ects morbidity and mortality (1). 
Lowering the phosphate load and maintaining serum 
phosphorus levels within the normal range are con-
sidered important therapeutic goals to improve clin-
ical outcomes in CKD patients. Treatment consists of 
diminishing intestinal phosphate absorption by a low 
phosphate diet and phosphate binders, however, their 
ei  cacy is ot en limited by poor adherence (2).
h e aim of this multicenter, cross-sectional, observa-
tional study was to investigate correlation of self-re-
ported medication adherence with serum phosphate 
levels and nutritional status in hemodialysis patients. 
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PATIENTS AND METHODS
Adult subjects receiving dialysis treatment for end-
stage renal disease were recruited from three Croa-
tian dialysis centers (Zagreb, 99 patients; Rijeka, 91 
patients; and Avitum, 105 patients), one center from 
Bosnia and Herzegovina (Sarajevo, 73 patients), and 
one center from Montenegro (Podgorica, 49 patients). 
Subjects were eligible for participation if they were 
aged 18 years or older and currently prescribed phos-
phate binder medication therapy. Exclusion criterion 
was the existing diagnosis of psychosis or dementia. 
Demographic information was collected by subject 
interview, while pill burden was documented at er 
review of medication containers and coni rmed by 
subject interview. Comorbidity and laboratory results 
were abstracted from medical charts and records. Lab-
oratory data were collected for the past three months, 
and the mean of all measured values over the three-
month period was used for analysis. Malnutrition In-
l ammation Score (MIS) (3) was determined. h e self-
made modii cation of Morisky Medication Adherence 
Scale (MMAS) (4) was used to determine self-reported 
medi cation adherence. Each positive answer is scored 
one point. h e scale range is 0-8, with 0 denoting most 
compliant and 8 least compliant. Surveys were admin-
istered to each subject during a face-to-face interview, 
before dialysis treatment.
h e study was conducted according to ethical stan-
dards. Informed consent was obtained from all partic-
ipants included in the study. 
Statistical analysis was performed using Stata/SE 11.2 
for Windows (StataCorp LP, USA). Dif erences be-
tween two groups were analyzed by Pearson 2-test 
(or Fisher exact test if any expected cell frequency in 
contingency table was ≤5) for categorical variables, by 
Student’s t-test for normally distributed continuous 
variables, and by Mann Whitney U test for non-nor-
mally distributed continuous variables, at the level of 
signii cance p<0.05. Spearman rank order correlation 
was used to determine correlation between variables. 
RESULTS
h e multinational study included 417 prevalent he-
modialysis patients. Characteristics of study subjects 
are presented in Table 1.
Table 1. 
Characteristics of the study population
Parameter Mean (range)
Age (yrs) 63.825 (21-92)
Dialysis vintage (months) 68.674 (3-456)
Body mass index (kg/m2) 25.66 (16.6-70)
Hemoglobin (g/L) 107.86 (63-142)
Prealbumin (g/L) 0.411 (0.12-0.9)
Albumin (g/L) 38.25 (23.6-41)
Phosphorus (mmol/L) 1.65 (0.37-3.5)
iPTH (pmol/L) 41.42 (0.2-166)
Kt/V 1.31 (0.6-2.5)
Residual diuresis (L) 183.48 (0-4000)
MIS 6.78 (0-17)
No. of pills 7.72 (1-23)
Adherence score 6.33 (0-8)
Data are presented as mean with range and standard devi-
ation; iPTH, intact parathyroid hormone; MIS, malnutri-
tion-inl ammation score
Sarajevo and Podgorica had a signii cantly higher, and 
Zagreb and Avitum signii cantly lower Morisky score, 
whereas Rijeka dif ered signii cantly from all other 
centers (Figure 1).
Fig. 1. Self-reported adherence score in dif erent dialysis centers 
h ese results were in contrast with the number of pre-
scribed pills (Figure 2) and MIS (Figure 3).
Fig. 2. Number of pills prescribed in dif erent dialysis centers. 
Patients from Podgorica had a signii cantly lower number of 
pills prescribed per day compared to other centers.
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Signii cant correlation was found between Morisky 
score and serum hemoglobin, prealbumin, albumin, 
phosphorus, Kt/V and residual diuresis. On the other 
hand, pill load (number of pills) correlated signii cant-
ly with residual diuresis, serum prealbumin, serum 
glucose, triglycerides, ferritin, and ultrai ltration vol-
ume (Table 2). 
Fig. 1. Malnutrition Inl ammation Score 
Table 2. 
Spearman rank order correlations
Variable No. of pills Morisky score
Correlation coeffi cient
Age (yrs) -0.071477 -0.091643
Dialysis vintage (months) 0.012715 -0.084853
BMI (kg/m2) 0.046584 0.013244
UF volume (L) 0.125004# -0.027500
Hemoglobin (g/L) 0.043909 -0.187647#
Ferritin (ug/L) 0.201665# -0.063710
C-reactive protein (mg/L) 0.039986 -0.031973
Creatinine (umol/L) -0.072086 0.075605
Glucose (mmol/L) 0.158771# -0.061612
Bicarbonates (mmol/L) -0.010552 0.004451
Prealbumin (g/L) 0.154281# -0.227937#
Albumin (g/L) 0.048469 -0.100130#
Cholesterol (mmol/L) 0.020321 0.066326
Triglycerides (mmol/L) 0.112518# 0.053302
Magnesium (mmol/L) -0.035197 0.097824
Calcium (mmol/L) 0.014945 0.017921
Phosphorus (mmol/L) -0.058356 0.192388#
iPTH (pmol/L) 0.050372 0.074018
Kt/V 0.091101 -0.106728#
Residual diuresis (L) 0.241750# -0.119067#
MIS 0.044434 -0.065495
#correlation signii cant at p<0.05; BMI, body mass index; 
iPTH, intact parathyroid hormone; MIS, malnutrition-in-
l ammation score
Patients with phosphate levels within the target range 
had a signii cantly lower Morisky score (better com-
pliance) than patients with increased phosphate lev-
els (Figure 4). h ere was no dif erence either between 
patients with iPTH within the target range (less than 
9-fold normal level) and patients with higher values, 
or between those with hemoglobin between 100 and 
120 g/L and those with lower hemoglobin values.
Fig. 4. Patients with serum phosphate levels within the target 
values had a signii cantly lower Morisky score compared to 
patients with higher phosphate levels.
DISCUSSION
Study results demonstrated signii cant relationship 
between the self-reported medication adherence and 
serum phosphate levels. Patients with lower adher-
ence determined by the Morisky score had higher 
serum phosphate levels. According to our results, the 
number of daily ingested pills correlated signii cantly 
with residual diuresis, serum prealbumin, serum glu-
cose, triglycerides, ferritin and ultrai ltration volume, 
but not with the self-reported medication adherence. 
Signii cant dif erences were recorded between dialysis 
centers from Croatia (Zagreb, Rijeka, and Avitum) and 
those from Bosnia and Herzegovina and Montene-
gro. h e main reason for these dif erences may be the 
long-standing practice of individual patient education 
in Croatian dialysis centers, which starts at the predial-
ysis stage and continues during dialysis treatment with 
emphasis on nutrition and use of phosphate binders 
based on phosphorus content in each meal. h us, de-
mographic parameters strongly inl uenced the results.
Maintenance of phosphorus control in dialysis pa-
tients is based on nutritional advice to balance phos-
phate content of the diet with the use of oral phosphate 
binders. h e majority of binders were studied using 
the traditional breakfast, lunch and dinner meal mod-
el. However, the majority of dialysis patients eat either 
more small frequent meals and snacks, which may 
decrease the ef ectiveness of the binders, or only one 
or two meals per day. Adherence to phosphate binder 
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use as prescribed was estimated to be less than 50% 
(5,6). Individual approach is mandatory because pa-
tients dif er signii cantly according to age, health liter-
acy, cognitive function, and adherence. It is up to the 
dialysis medical team to keep patients interested with 
consistent and creative communication. 
To the best of our knowledge, we demonstrated cor-
relation between the parameters of nutritional status 
(prealbumin and albumin) with self-reported medica-
tion adherence for the i rst time. h is may be an im-
portant i nding revealing that excellent results may be 
achieved with a more liberal diet in patients compliant 
with the use of phosphate binders. h ese i ndings are 
in line with previous i ndings demonstrating the most 
favorable outcomes in patients with high protein in-
take and good phosphate control (7). Correlation of 
Morisky score with residual diuresis may be an addi-
tional important i nding, showing that compliant pa-
tients may preserve residual renal function. 
h ere were several limitations to this study. First, the 
cross-sectional study design made it dii  cult to deter-
mine temporal sequencing. Second, our sample size 
was small. Finally, we used a self-reported measure of 
phosphate binder adherence, which is subject to recall 
and information bias (although validated) (4).
In conclusion, self-reported medication adherence 
signii cantly correlated with serum phosphate levels, 
residual diuresis and nutritional status in dialysis pa-
tients. Signii cant dif erences existed among dialysis 
centers, with better results achieved in the centers with 
structured predialysis and dialysis education.
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Suradljivost je glavna prepreka kontroli fosfora u većine bolesnika sa završnim stadijem kronične bubrežne bolesti. Istražili 
smo povezanost suradljivosti s uzimanjem lijekova, procijenjene od strane samih bolesnika, s koncentracijom fosfora u 
serumu i statusom uhranjenosti bolesnika na hemodijalizi. U istraživanje je uključeno 417 bolesnika iz Hrvatske, Crne 
Gore i Bosne i Hercegovine. Prosječna dob bila je 63,82 godine (raspon, 21-92), 55,1 % ih je bilo muškog spola, prosječno 
liječenih dijalizom 68,67 (raspon, 3-456) mjeseci. Nađena je statistički značajna pozitivna korelacija između suradljivosti 
i serumskog fosfora (0,192), a negativna s prealbuminom, albuminom, Kt/V i ostatnom diurezom (redom, -0,187, -0,227, 
-0,100, 0,192 i -0,106). S druge strane, broj dnevno unesenih tableta je statistički značajno korelirao s ostatnom diurezom, 
serumskim prealbuminom, glukozom, trigliceridima, feritinom i volumenom ultrafi ltracije (redom, 0,241, 0,154, 0,158, 0,112, 
0,201 i 0,125). Zaključno, samoprocijenjena suradljivost bolesnika korelira sa serumskim fosforom, ostatnom diurezom i 
statusom uhranjenosti bolesnika na hemodijalizi.
Ključne riječi: suradljivost, fosfor, status uhranjenosti, količina lijekova
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